首页> 外文期刊>Journal of Young Pharmacists >Exploring troublesome symptom and problems experienced by cancer patients undergoing chemotherapy.
【24h】

Exploring troublesome symptom and problems experienced by cancer patients undergoing chemotherapy.

机译:探索麻烦的症状和接受化疗的癌症患者遇到的问题。

获取原文
           

摘要

Objective: The objective of this cross-sectional, non interventional 8-months observational study was to investigate the prevalence, type and risk factors of Drug related problem (DRPs) in cancer patients admitted to the Oncology Department of Guru Gobind Singh Medical College, Faridkot, Punjab. Methods: A cross-sectional 8 months study was conducted from January to August 2015 at the Oncology Department of Guru Gobind Singh Medical College, Faridkot, Punjab. A total of 283 cancer patients were recruited in the present investigation analysis. Results: A total of 283 cancer patients participated in this current study, out of which 135 (47.70%) were males and 148 (52.30%) were females. Adverse drug reactions (ADRs) were the most common DRP, nausea and vomiting was the most common ADR (155). Female subjects experienced more DRPs 56% as compare to 44% in male cancer survivors. Conclusion: This study showed that DRPs were common in our setup and the risk factors associated with DRPs were female gender, number of medications, Body mass index and extremes age (in year) ranges. Early detection and timely intervention is the key to ensure a better therapeutic outcome.
机译:目的:这项为期8个月的非干预性横断面观察性研究的目的是调查法瑞德(Faridkot)古鲁·戈宾德·辛格医学院(Guru Gobind Singh Medical College)肿瘤科收治的癌症患者中与药物相关的问题(DRP)的患病率,类型和危险因素旁遮普。方法:2015年1月至2015年8月在旁遮普邦法里德科特的古鲁·戈宾德·辛格医学院肿瘤系进行了为期8个月的横断面研究。在本研究分析中,总共招募了283名癌症患者。结果:总共283位癌症患者参加了本研究,其中135位(47.70%)是男性,148位(52.30%)是女性。药物不良反应(ADR)是最常见的DRP,恶心和呕吐是最常见的ADR(155)。女性受试者的DRPs更高,为56%,而男性癌症幸存者为44%。结论:这项研究表明,在我们的机构中​​常见DRPs,并且与DRPs相关的危险因素是女性,用药数量,体重指数和极端年龄(年)范围。早期发现和及时干预是确保更好的治疗效果的关键。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号